chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 10.0
Sex: M
Vaccine: MEN
Symptoms: Medication error, No adverse event, Poor quality product administered, Product storage error
Clinical narrative: vaccine temperature execursion at 31.5° fahrenheit for 2 hours 45 minutes was administered to the patient with no reported adverse event; Initial information received on 04-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to case 2023SA239548.  This case involves a 10 years old male patient for whom vaccine Meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] was administered to the patient after temperature excursion at 31.5° Fahrenheit for 2 hours 45 minutes with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Diphtheria Vaccine Toxoid, Pertussis Vaccine Acellular 5-Component, Tetanus Vaccine Toxoid (Adacel) for Prophylactic vaccination.  On an unknown date in Jun-2023, the patient received a dose of 0.5 ml suspect Meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] (solution for injection) (route, administration site, lot number; strength; expiry date unknown) for Immunization, after temperature excursion at 31.5° fahrenheit for 2 hours 45 minutes due to potential mechanical issue with the refrigerator with no reported adverse event (Poor quality product administered) (latency: same day). Information regarding batch number was requested in the case.   It was reported, "Adacel, Daptacel, IPOL, Menquadfi, Pentacel, Quadracel, Tenivac, Vaxelis. Product activated/prepared? NO Due to a human error: NO and Does extended stability data cover the excursion: NO These vaccines were administered to 40 patients over a span of 1 week, starting on 15Jun2023 till stopping at 22Jun2023."  No lab data reported.  Action taken: not applicable.  At time of reporting, the outcome was Unknown.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.17
Sex: F
Vaccine: MEN
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: menquadfi was given to a 2 month old with no reported adverse event; Initial information received on 08-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 9 weeks old/ (2-month-old) female patient who was given meningococcaL A-C-Y-W135 (T CONJ) vaccine [Menquadfi] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, hepatitis B vaccine RHBSAG (yeast), pertussis vaccine acellular 3-component, polio vaccine INACT 3V (VERO), tetanus vaccine toxoid (Pediarix); pneumococcal vaccine CONJ 15V (CRM197) (Vaxneuvance); and rotavirus vaccine live oral 1v (Rotarix) for Prophylactic vaccination.  On 07-Aug-2023, the 2 month old patient received a standard dose of 0.5 ml of suspect meningococcaL A-C-Y-W135 (T CONJ) vaccine Solution for injection (lot U7595AA, expiry date- 11-MAR-2025) via intramuscular route in the left thigh for Immunization with no reported adverse event (product administered to patient of inappropriate age) (latency- same day).  Reportedly, Caller says a medical assistant gave MENQUADFI to a 2 month old and she wants to know what to look for or if they need to do anything.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.25
Sex: M
Vaccine: HIBV
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: medical Assistant reported that she has administered a Vaccine (ACTHIB) that has expired yesterday to a patient with no reported adverse event; Initial information received on 08-Aug-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 15 months old male patient and medical assistant reported that she has administered a vaccine (acthib) that has expired yesterday to a patient with no reported adverse event while receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Prophylactic vaccination.  On 06-Oct-2022, the patient received a dose 1 of suspect HIB (PRP/T) VACCINE Powder and solvent for solution for injection and on 11-Aug-2022 he also received a dose 2 same vaccine  (with an unknown dosage, strength, expiry date and batch number) via unknown route for prophylactic vaccination (immunization).  On 08-Aug-2023 he also received a dose 3 at a dose of 0.5 ml of the same vaccine (Frequency: once, strength: standard, expiry date: 07-Aug-2023 and lot UJ735AA) via intramuscular route in the right thigh for  prophylactic vaccination (immunization) and medical assistant reported that she has administered a vaccine (acthib) that has expired yesterday to a patient with no reported adverse event (expired product administered) (latency: same day).  Information on the batch number was requested.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Medication error, No adverse event, Single component of a two-component product administered
Clinical narrative: Pharmacist said that a nurse only injected the DTap-IPV component of the PENTACEL to a patient before mixing it, with no reported adverse event; Initial information received on 08-Aug-2023 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 4 years old male patient who was only injected the dtap-ipv component of the diphtheria/ tetanus/ 5 hybrid AC pertussis/ IPV(vero)/ HIB(PRP/T) vaccine [Pentacel (Vero)] before mixing it, with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 08-Aug-2023, the patient received 0.5 mL last dose of suspect diphtheria/ tetanus/ 5 hybrid AC pertussis/ IPV(vero)/ HIB(PRP/T) vaccine, suspension for injection (batch number, expiry date unknown) via intramuscular route in unknown administration site for immunization, only the dtap-ipv component of the pentacel was injected before mixing it, with no reported adverse event (single component of a two-component product administered) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event pharmacist said that a nurse only injected the dtap-ipv component of the pentacel to a patient before mixing it, with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: DTAP, TDAP
Symptoms: Medication error, No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: fully vaccinated 12 year old patient was administered DAPTACEL instead of ADACEL with no reported adverse event; fully vaccinated 12 year old patient was administered DAPTACEL instead of ADACEL with no reported adverse event; Initial information received on 08-Aug-2023 and live follow up received on same date both were processed together regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a fully vaccinated 12 years old patient to whom daptacel was administered instead of adacel with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, fully vaccinated 12 years old patient was administered diphtheria, tetanus and acellular pertussis vaccine (daptacel), suspension for injection instead of adacel with no reported adverse event (wrong product administered) (Product administered to patient of inappropriate age) (latency same day) (strength, dose, route, site, batch number and expiry date: unknown) Information on the batch number was requested  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event wrong product administered.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Fatigue, Mobility decreased
Clinical narrative: Extreme, debilitating fatigue. I stayed in bed for 20 hours, pretty much unable to move.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Seizure
Clinical narrative: It appeared to both me and the patient's mother that the patient had a short seizure about 5 minutes after vaccination with Menveo. The patient's mother is going to take her son to the ER for follow-up.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Ill-defined disorder, Pain, Premenstrual dysphoric disorder, Premenstrual syndrome
Clinical narrative: premenstrual dysphoric disorder (PMDD); painful Premenstrual syndrome; among other severe symptoms; This spontaneous report was received from a lawyer regarding a case in litigation and referred to a currently 26-year-old female patient. No information was provided regarding concomitant medications, concurrent conditions or medical history. On 17-SEP-2021, the patient was vaccined with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection for prophylaxis(strength, dose,lot #, expiry date and route of administration were not provided). On unknown dates, the patient developed premenstrual dysphoric disorder (PMDD), painful premenstrual syndrome (PMS) and among other severe symptoms (ill-defined disorder). The outcome of all events was not reported. The lawyer considered the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) caused th ose events.
Sex: U
Vaccine: COVID19-2
Symptoms: Neoplasm malignant
Clinical narrative: cancer; This spontaneous case was reported by a consumer and describes the occurrence of NEOPLASM MALIGNANT (cancer) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEOPLASM MALIGNANT (cancer) (seriousness criteria death and medically significant). The reported cause of death was Cancer. It is unknown if an autopsy was performed.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NEOPLASM MALIGNANT (cancer) to be related.    It was unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. It was reported that the Moderna Covid-19 caused cancer in 25 patients who were the friends of reporter. The patient will not provide any additional information on these patients. It was also reported that those patients who died were killed by the Moderna Covid-19 vaccine because Moderna vaccine was poison Cancer rates for jabbed Moderna Cancer patients was up 300% The Doctors are part of it along with Moderna. Treatment details was not reported by the reporter. This case contains information about 6th patient out of 25 patients. Company comment: This spontaneous case concerns a patient of unknown age and gender, with no medical history reported who experienced the unexpected, serious (due to medically significant and death criteria) event of Neoplasm malignant after a dose of mRNA-1273 vaccine was administered. Temporal association cannot be assessed due to lack of information on onset date of the event. The reported cause of death was Cancer. It is unknown if an autopsy was performed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-735987 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735987:Master case; Reported Cause(s) of Death: Cancer
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Seizure; This spontaneous case was reported by a patient and describes the occurrence of SEIZURE (Seizure) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SEIZURE (Seizure) (seriousness criterion medically significant). At the time of the report, SEIZURE (Seizure) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported.  Company comment:  This spontaneous case concerns a 72  year  old male patient, with no medical history reported, who received a dose of mRNA  1273 original vaccine (reported as second dose of his COVID  19 vaccination schedule) and experienced the unexpected, serious (medically significant) AESI seizure. Latency cannot be properly assessed since exact onset date and vaccination date were not provided. The report stated that the patient had one event of seizure. No further clinical details were provided for medical reviewing. The benefit-risk relationship of mRNA  1273 original vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-735528 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735528:Bivalent case
Sex: U
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: pulmonary embolism; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY EMBOLISM (pulmonary embolism) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Patient had no information about previous COVID-19 vaccination doses. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PULMONARY EMBOLISM (pulmonary embolism) (seriousness criterion medically significant). At the time of the report, PULMONARY EMBOLISM (pulmonary embolism) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Suspect product dosage text was reported as unknown. No treatment medication was reported. Company Comment: This is a spontaneous case concerning patient of an unknown age and gender with no reported medical history, who experienced the serious (due to medically significant) unexpected, AESI event of pulmonary embolism, which occurred on an unknown date after a dose of mRNA-1273 vaccine (unknown COVID-19 vaccination schedule). No further information was disclosed. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.    This case was linked to US-MODERNATX, INC.-MOD-2023-735564, US-MODERNATX, INC.-MOD-2023-735503 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735564:Invalid case US-MODERNATX, INC.-MOD-2023-735503:Same reporter
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness
Clinical narrative: Passed out; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (Passed out) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 on 26-Dec-2022. Concurrent medical conditions included Pain in arm, Painful arm and Pain in upper extremities. Concomitant products included IBUPROFEN for Pain in arm, SPIRONOLACTONE, CARIPRAZINE HYDROCHLORIDE (VRAYLAR) and LAMOTRIGINE for an unknown indication.    On 01-Aug-2023, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Aug-2023, the patient experienced LOSS OF CONSCIOUSNESS (Passed out) (seriousness criterion medically significant). At the time of the report, LOSS OF CONSCIOUSNESS (Passed out) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that patient had little nauseous, then very nauseous, then passed out and it's like hit on head.  It was unknown if the patient experienced any additional symptoms/events. There were no lab data/results available No treatment medications were reported. Company comment- This is a spontaneous case concerning a 33-year-old- female patient with no relevant medical history reported who experienced the serious (medically significant) and unexpected event of loss of consciousness after a dose of mRNA-1273 vaccine, given as a fourth dose of COVID vaccine schedule, was administered. It was reported patient felt a little nauseous, then very nauseous, and then passed out and hit her head. No further details were provided for medical review. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, UNSPECIFIED
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Received second shingles vaccine Since then have required physical therapy to my left arm and shoulder for pain from the injection.
Sex: F
Vaccine: MMR
Symptoms: Product use issue
Clinical narrative: MMR Vaccine given as post hematopoietic stem cell transplant vaccine schedule when patient was still receiving chemotherapy. MMR only recommended if patient on observation due to it being a live vaccine.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood immunoglobulin E increased, Blood immunoglobulin M decreased, Blood test, Bradykinesia
Clinical narrative: Woke up in mid July 2022 feeling like a house fell on me. Extreme fatigue felt feverish eyes burned. Lasted three months went to ER twice once in mid September once in mid October psych bc I was so sick it was making me feel hopeless. The debilitating fatigue has lasted until today and continues every morning I wake up. I cannot do my regular activities to keep up my house or self or pets. I am a widow of 13 years and have felt this deathly exhausted dialed down mentally as well. Can?t think to even clean out the litter box. I?ve been to specialists immunologists functional md holistic hair sample analysis gut map nothing even touches it. I?m going for infusions to see if high doses of vitamins and anti inflammatory work. Three infusions no changes whatever. This has changed my life so horribly that I have no life left in me. Barely can walk my dog. I have muscle weakness and slowness that I can?t walk up my indoor stairs without stopping.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Epstein-Barr virus test, Eye irritation, Fatigue, Feeling abnormal, Feeling of despair
Clinical narrative: Woke up in mid July 2022 feeling like a house fell on me. Extreme fatigue felt feverish eyes burned. Lasted three months went to ER twice once in mid September once in mid October psych bc I was so sick it was making me feel hopeless. The debilitating fatigue has lasted until today and continues every morning I wake up. I cannot do my regular activities to keep up my house or self or pets. I am a widow of 13 years and have felt this deathly exhausted dialed down mentally as well. Can?t think to even clean out the litter box. I?ve been to specialists immunologists functional md holistic hair sample analysis gut map nothing even touches it. I?m going for infusions to see if high doses of vitamins and anti inflammatory work. Three infusions no changes whatever. This has changed my life so horribly that I have no life left in me. Barely can walk my dog. I have muscle weakness and slowness that I can?t walk up my indoor stairs without stopping.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Gastrointestinal pathogen panel, Infusion, Laboratory test, Laboratory test abnormal
Clinical narrative: Woke up in mid July 2022 feeling like a house fell on me. Extreme fatigue felt feverish eyes burned. Lasted three months went to ER twice once in mid September once in mid October psych bc I was so sick it was making me feel hopeless. The debilitating fatigue has lasted until today and continues every morning I wake up. I cannot do my regular activities to keep up my house or self or pets. I am a widow of 13 years and have felt this deathly exhausted dialed down mentally as well. Can?t think to even clean out the litter box. I?ve been to specialists immunologists functional md holistic hair sample analysis gut map nothing even touches it. I?m going for infusions to see if high doses of vitamins and anti inflammatory work. Three infusions no changes whatever. This has changed my life so horribly that I have no life left in me. Barely can walk my dog. I have muscle weakness and slowness that I can?t walk up my indoor stairs without stopping.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Malaise, Mental fatigue, Mental impairment, Muscular weakness
Clinical narrative: Woke up in mid July 2022 feeling like a house fell on me. Extreme fatigue felt feverish eyes burned. Lasted three months went to ER twice once in mid September once in mid October psych bc I was so sick it was making me feel hopeless. The debilitating fatigue has lasted until today and continues every morning I wake up. I cannot do my regular activities to keep up my house or self or pets. I am a widow of 13 years and have felt this deathly exhausted dialed down mentally as well. Can?t think to even clean out the litter box. I?ve been to specialists immunologists functional md holistic hair sample analysis gut map nothing even touches it. I?m going for infusions to see if high doses of vitamins and anti inflammatory work. Three infusions no changes whatever. This has changed my life so horribly that I have no life left in me. Barely can walk my dog. I have muscle weakness and slowness that I can?t walk up my indoor stairs without stopping.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Woke up in mid July 2022 feeling like a house fell on me. Extreme fatigue felt feverish eyes burned. Lasted three months went to ER twice once in mid September once in mid October psych bc I was so sick it was making me feel hopeless. The debilitating fatigue has lasted until today and continues every morning I wake up. I cannot do my regular activities to keep up my house or self or pets. I am a widow of 13 years and have felt this deathly exhausted dialed down mentally as well. Can?t think to even clean out the litter box. I?ve been to specialists immunologists functional md holistic hair sample analysis gut map nothing even touches it. I?m going for infusions to see if high doses of vitamins and anti inflammatory work. Three infusions no changes whatever. This has changed my life so horribly that I have no life left in me. Barely can walk my dog. I have muscle weakness and slowness that I can?t walk up my indoor stairs without stopping.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Focal dyscognitive seizures, Partial seizures
Clinical narrative: COMPLEX PARTIAL EPILEPSY EPILEPSY, UNSPECIFIED
Age: 65.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Laboratory test normal, Lung infiltration
Clinical narrative: A 67 y.o male with PMH with parkinson, TIA and pseudogout found to be +COVID-19 no signs of sepsis or SIRS. No leukocytosis. Labs unremarkable. No hypoxia. CXR with infiltrate vs atelectasis independently reviewed. Could be post COVID but given patient symptoms will cover with bordered broad-spectrum antibiotic with vancomycin and Zosyn for possible superimposed infection.  Will monitor renal function with labs in the morning to evaluate for side effect. Urinalysis was negative for UTI.  Will order blood cultures.  No indication for therapy for COVID-19 given the onset of symptom in more than 2 weeks and not being hypoxic
Age: 65.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Malaise, SARS-CoV-2 test positive, Urine analysis normal
Clinical narrative: A 67 y.o male with PMH with parkinson, TIA and pseudogout found to be +COVID-19 no signs of sepsis or SIRS. No leukocytosis. Labs unremarkable. No hypoxia. CXR with infiltrate vs atelectasis independently reviewed. Could be post COVID but given patient symptoms will cover with bordered broad-spectrum antibiotic with vancomycin and Zosyn for possible superimposed infection.  Will monitor renal function with labs in the morning to evaluate for side effect. Urinalysis was negative for UTI.  Will order blood cultures.  No indication for therapy for COVID-19 given the onset of symptom in more than 2 weeks and not being hypoxic
Age: 71.0
Sex: F
Vaccine: UNK
Symptoms: Asthenia, COVID-19, Productive cough, SARS-CoV-2 test positive
Clinical narrative: Pt tested positive for Covid. Pt states she is feeling weak and having a productive cough. Pt does not have any hx with pulmonary disease.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 1/15/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 74.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Sepsis
Clinical narrative: Sepsis with Acute hypoxic respiratory failure -2/2 COVID-19 PNA.  Currently on-on NC.  Titrate to keep sats 92-96% Remdesivir- yes
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Deep vein thrombosis, Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: OBSTRUCTIVE SLEEP APNEA ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN ACUTE DVT OF RIGHT FEMORAL VEIN ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/29/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY
Age: 3.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Extra dose administered
Clinical narrative: DTaP and IPV was combined as Kinrix when it was supposed to stay separate.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Loss of consciousness, Pallor
Clinical narrative: After receiving the Men B vaccine patient became pale and passed out.  Patient woke up after about 20 sec in a panic asking for her mom.  Nurse brought in a CNP to check over the patient.  Patient was asked to lie down with her feet elevated and was given OJ with graham crackers.  After about 10 min the CNP rechecked the patient before sending them home.
Age: 16.0
Sex: F
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: Patient was accidentally given a vaccine that had expired on 02/06/2023.  Patient did not experience any adverse events.  Patient will come back to the pharmacy to receive a non-expired second dose.
Age: 0.75
Sex: F
Vaccine: HEP, MENB
Symptoms: Cough, Decreased appetite, Laboratory test, Pyrexia, Rhinorrhoea
Clinical narrative: Patient started having a fever on 08/09/2023 with the highest temp of 105. She has had a runny nose and cough. Eating less than usual. No bowel movement . Where the wrong vaccine was given the leg is bruised and swollen, redness around the area.
Age: 0.75
Sex: F
Vaccine: HEP, MENB
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site swelling, Wrong product administered
Clinical narrative: Patient started having a fever on 08/09/2023 with the highest temp of 105. She has had a runny nose and cough. Eating less than usual. No bowel movement . Where the wrong vaccine was given the leg is bruised and swollen, redness around the area.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 11.0
Sex: F
Vaccine: HPV9, MENB, MNQ, TDAP
Symptoms: Unevaluable event
Clinical narrative: Patient received 4 vaccines during appointment. Patient's guardian,  authorized 2 of the 4 vaccinations (Tdap and Meningococcal). Patient's guardian  was present during administration of the vaccines. After the patient and her guardian left the office, it was found that the guardian only authorized the 2 vaccines. Health Department left voicemail on guardian's cell at 4:31 PM. Health Department spoke to guardian on Friday, August 11 at 8:25 AM. Guardian stated outrage regarding the administering of the 2 other vaccinations and requested documentation regarding her consent. Side effects and vaccine appropriateness explained. Requested documentation and educational materials were placed in the mail today at 9:05 AM.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: HYPOXIA 12/2/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Pneumonia
Clinical narrative: Patient sx of worsening SOB. Initially admitted to a HCF from 7/22/23-7/26/23. Discharged home and readmitted to another Hospital on 8/7/23 for continued SOB and Pneumonia.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Skin depigmentation, Vitiligo
Clinical narrative: Vitiligo - clear loss of pigmentation on hands and other places  Never had this before.  No family history that patient knows of.  Waiting for treatment options, dependent on approval by insurance company (which currently is refusing to cover).
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Death, Sepsis
Clinical narrative: Patient expired 7/27/23 Pt sen to ER today for sepsis with covid
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Cough, Fall
Clinical narrative: emergency room because of generalized weakness status post fall due to weakness inability to get up and pain from the fall he admit having some cough but he deny any shortness of breath he denies any nausea or vomiting abdominal pain in the emergency room COVID-19 did come back positive for COVID-19 infection  admitted to floor started for zosyn for possible PNA , but CXR back unremarkable , home meds started , treated supportive mangement for COVID , pt currently on RA
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Pain, SARS-CoV-2 test positive
Clinical narrative: emergency room because of generalized weakness status post fall due to weakness inability to get up and pain from the fall he admit having some cough but he deny any shortness of breath he denies any nausea or vomiting abdominal pain in the emergency room COVID-19 did come back positive for COVID-19 infection  admitted to floor started for zosyn for possible PNA , but CXR back unremarkable , home meds started , treated supportive mangement for COVID , pt currently on RA
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Nausea, Pain
Clinical narrative: developed headache, body aches and nausea
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram thorax normal, Dehydration, Diarrhoea
Clinical narrative: presented with Dehydration sec to nausea, vomiting and diarrhea. She was started on IVF with resolution of her symptoms and it was felt these are related to a viral infection. She did hyponatremia and hypokalemia. The former has now resolved and the later is being replaced. She tested positive for covid but with no pulmonary symptoms and no evidence of pneumonia on CXR or chest CT.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypokalaemia, Hyponatraemia, Nausea, SARS-CoV-2 test positive, Viral infection
Clinical narrative: presented with Dehydration sec to nausea, vomiting and diarrhea. She was started on IVF with resolution of her symptoms and it was felt these are related to a viral infection. She did hyponatremia and hypokalemia. The former has now resolved and the later is being replaced. She tested positive for covid but with no pulmonary symptoms and no evidence of pneumonia on CXR or chest CT.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: presented with Dehydration sec to nausea, vomiting and diarrhea. She was started on IVF with resolution of her symptoms and it was felt these are related to a viral infection. She did hyponatremia and hypokalemia. The former has now resolved and the later is being replaced. She tested positive for covid but with no pulmonary symptoms and no evidence of pneumonia on CXR or chest CT.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood alkaline phosphatase increased, Blood lactic acid, COVID-19, Chest X-ray abnormal, Cough
Clinical narrative: Presents hospital with worsening cough and shortness of breath In the emergency department patient was found (+) sirs (tachypnea; leukocytosis -10.75); acute hypoxia saturating well on 2 L nasal cannula; lactic acid (1.6); elevated alkaline phosphatase (217); elevated troponin (23); elevated D-dimer (2.37); elevated acute phase reactant; (-) Legionella and strep; respiratory PCR shows (+) COVID-19; chest x-ray independently reviewed and patient has opacities diffused in both lungs concerning for atypical pneumonia  COVID-19 pneumonia patient was initially treated with remdesivir, IV antibiotics, which he completed a course of ceftriaxone and discontinued off of further antibiotics per ID
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Fibrin D dimer increased, Hypoxia, Inflammatory marker increased, Legionella test
Clinical narrative: Presents hospital with worsening cough and shortness of breath In the emergency department patient was found (+) sirs (tachypnea; leukocytosis -10.75); acute hypoxia saturating well on 2 L nasal cannula; lactic acid (1.6); elevated alkaline phosphatase (217); elevated troponin (23); elevated D-dimer (2.37); elevated acute phase reactant; (-) Legionella and strep; respiratory PCR shows (+) COVID-19; chest x-ray independently reviewed and patient has opacities diffused in both lungs concerning for atypical pneumonia  COVID-19 pneumonia patient was initially treated with remdesivir, IV antibiotics, which he completed a course of ceftriaxone and discontinued off of further antibiotics per ID
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Leukocytosis, Lung opacity, SARS-CoV-2 test positive, Streptococcus test negative, Systemic inflammatory response syndrome
Clinical narrative: Presents hospital with worsening cough and shortness of breath In the emergency department patient was found (+) sirs (tachypnea; leukocytosis -10.75); acute hypoxia saturating well on 2 L nasal cannula; lactic acid (1.6); elevated alkaline phosphatase (217); elevated troponin (23); elevated D-dimer (2.37); elevated acute phase reactant; (-) Legionella and strep; respiratory PCR shows (+) COVID-19; chest x-ray independently reviewed and patient has opacities diffused in both lungs concerning for atypical pneumonia  COVID-19 pneumonia patient was initially treated with remdesivir, IV antibiotics, which he completed a course of ceftriaxone and discontinued off of further antibiotics per ID
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tachypnoea, Troponin increased
Clinical narrative: Presents hospital with worsening cough and shortness of breath In the emergency department patient was found (+) sirs (tachypnea; leukocytosis -10.75); acute hypoxia saturating well on 2 L nasal cannula; lactic acid (1.6); elevated alkaline phosphatase (217); elevated troponin (23); elevated D-dimer (2.37); elevated acute phase reactant; (-) Legionella and strep; respiratory PCR shows (+) COVID-19; chest x-ray independently reviewed and patient has opacities diffused in both lungs concerning for atypical pneumonia  COVID-19 pneumonia patient was initially treated with remdesivir, IV antibiotics, which he completed a course of ceftriaxone and discontinued off of further antibiotics per ID
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Chills, Fatigue, Myalgia, Nausea
Clinical narrative: I felt tired, had muscle pain, shivering, fever, stomach pain, and nausea. It lasted around 12 hours.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia, Vaccine positive rechallenge
Clinical narrative: I felt tired, had muscle pain, shivering, fever, stomach pain, and nausea. It lasted around 12 hours.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Covid-19 Breakthrough Infection
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site pain, Pain, Pyrexia, Rash maculo-papular
Clinical narrative: Fever, headache, body aches 1 day after vaccination Localized reaction of erythema, warmth, and pain at vaccination site Generalized maculopapular rash to all extremities, chest, abdomen, back, and face
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Fever, headache, body aches 1 day after vaccination Localized reaction of erythema, warmth, and pain at vaccination site Generalized maculopapular rash to all extremities, chest, abdomen, back, and face
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Partial seizures
Clinical narrative: FOCAL MOTOR SEIZURE
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE ST ELEVATION MI, UNSPECIFIED ACUTE NON ST ELEVATION MI
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: TYPE 2 MI
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: CRYPTOGENIC STROKE
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Diabetes mellitus
Clinical narrative: I21.19 ACUTE ST ELEVATION MI, INFERIOR WALL 4/17/2023 ACUTE ST ELEVATION MI, UNSPECIFIED    DIABETES REMOTE MONITORING I21.3 ACUTE ST ELEVATION MI, UNSPECIFIED 4/15/2023 ACUTE ST ELEVATION MI, UNSPECIFIED    DIABETES REMOTE MONITORING
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Heart rate increased, Throat tightness, Tremor
Clinical narrative: Patient reported rapid heart beat, shaking,  and throat tightness occurring around midnight after receiving vaccine around 11am.
Age: 1.5
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received combination vaccine, Kinrix (DTaP-IPV), at the age of 18 months old. Kinrix is licensed to be given to children between the ages of 4 ? 6yrs of age. No adverse reaction/event reported by patient/guardian at this time.
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood glucose normal, Cyanosis, Death, Malaise, Mouth breathing
Clinical narrative: At approximately 1510, DON was alerted by LPN, resident not feeling well. Initial assessment VS 97.8 110 32 117/63, purse lipped breathing with accessory muscle use, pallor with circumoral cyanosis, blood glucose 192. Resident only able to speak in 1-2 works phrases. Hands cold, unable to obtain pulse ox. Oxygen on at 2 L/M via nasal cannula.  Head of bed elevated to ease breathing, O2 changed over to mask at 5 LM.  Directed nurse to call and ask wife her wishes for care, resident rep requested transport to Facility. 911 initiated.  Call also placed to Dr., assessment reviewed, made her aware of resident rep request and 911 initiated, she is in agreement. Follow up assessment 163/89, 59, 43 97.6, no audible wheezing, mentation at baseline, color is dusky O2 on via mask at 5 L/M. EMS arrived, report provided, aware wife prefers Facility but medic states Reading due to proximity and acute needs of patient. Resident lifted to litter and taken to ambulance for transport.  Resident death was pronounced in ambulance in Parking lot at 1545 by EMS staff. Resident still transferred to Hospital after pronounce death. Dr. aware.
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pallor, Peripheral coldness, Skin discolouration, Speech disorder, Use of accessory respiratory muscles
Clinical narrative: At approximately 1510, DON was alerted by LPN, resident not feeling well. Initial assessment VS 97.8 110 32 117/63, purse lipped breathing with accessory muscle use, pallor with circumoral cyanosis, blood glucose 192. Resident only able to speak in 1-2 works phrases. Hands cold, unable to obtain pulse ox. Oxygen on at 2 L/M via nasal cannula.  Head of bed elevated to ease breathing, O2 changed over to mask at 5 LM.  Directed nurse to call and ask wife her wishes for care, resident rep requested transport to Facility. 911 initiated.  Call also placed to Dr., assessment reviewed, made her aware of resident rep request and 911 initiated, she is in agreement. Follow up assessment 163/89, 59, 43 97.6, no audible wheezing, mentation at baseline, color is dusky O2 on via mask at 5 L/M. EMS arrived, report provided, aware wife prefers Facility but medic states Reading due to proximity and acute needs of patient. Resident lifted to litter and taken to ambulance for transport.  Resident death was pronounced in ambulance in Parking lot at 1545 by EMS staff. Resident still transferred to Hospital after pronounce death. Dr. aware.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: ACUTE DVT, UNSPECIFIED VEIN
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Blood test, Computerised tomogram, Hypoaesthesia, Magnetic resonance imaging, Paraesthesia
Clinical narrative: Numbness and tingling in R side of face and R arm. Lasting 2+ days but improving over time. No treatment only diagnostic tests, all negative so far.
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Vitamin B12
Clinical narrative: Numbness and tingling in R side of face and R arm. Lasting 2+ days but improving over time. No treatment only diagnostic tests, all negative so far.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Left ventricular failure, Transient ischaemic attack
Clinical narrative: G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/5/2023 ACUTE NON ST ELEVATION MI  I21.4 ACUTE NON ST ELEVATION MI 3/29/2023 ACUTE NON ST ELEVATION MI  G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/5/2023 COMBINED SYSTOLIC AND DIASTOLIC HEART FAILURE, UNSPECIFIED ACUITY  I21.4 ACUTE NON ST ELEVATION MI 3/29/2023 COMBINED SYSTOLIC AND DIASTOLIC HEART FAILURE, UNSPECIFIED ACUITY  G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/5/2023 HX OF LEFT BELOW KNEE AMPUTATION  I21.4 ACUTE NON ST ELEVATION MI 3/29/2023 HX OF LEFT BELOW KNEE AMPUTATION
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Respiratory failure
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/29/2023 ACUTE HYPERCAPNIC RESPIRATORY FAILURE J96.02 ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/29/2023 ACUTE HYPERCAPNIC RESPIRATORY FAILURE
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute coronary syndrome
Clinical narrative: ACUTE CORONARY SYNDROME, UNSPECIFIED
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after BUD
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Patient received vaccine after BUD
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Headache, Nausea, Pain in extremity
Clinical narrative: PAIN TO RIGHT ARM, NAUSEA, HEADACHE
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperlipidaemia, Neuropathy peripheral
Clinical narrative: G62.9 NEUROPATHY 4/18/2023 HYPERLIPIDEMIA
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: HYPOXIA 1/17/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Incorrect route of product administration
Clinical narrative: Quadracel accidently given SQ instead of IM
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received vaccine one month early: #1 Shingrix 7/12/2023 #2 Shingrix 8/11/2023
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Facial paresis
Clinical narrative: RIGHT BELLS PALSY RIGHT FACIAL MUSCLE WEAKNESS